A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/21 (2006.01) A61P 31/18 (2006.01) A61P 37/04 (2006.01) C07K 1/107 (2006.01) C07K 14/16 (2006.01) C07K 16/10 (2006.01) G01N 33/543 (2006.01) G01N 33/564 (2006.01) G01N 33/569 (2006.01) G01N 33/68 (2006.01) A61K 39/39 (2006.01)
Patent
CA 2181590
The present invention releases to synthetic peptide analogues useful as therapeutic agents, immunogens or for the diagnosis of disease. In particular, it relates to peptide multimers which maintain the conformation of the native proteins from which they are derived. Peptomers constructed from peptides derived from gp120 of the human immunodeficiency virus are exemplified.
L'invention concerne des analogues de peptides synthétiques utiles en tant qu'agents thérapeutiques, immunogènes ou pour le diagnostic de maladies. Elle se rapporte, plus particulièrement, à des multimères peptidiques qui conservent la conformation des protéines natives desquelles ils sont dérivés. Des peptomères créés à partir de peptides dérivés de la protéine gp120 du virus du syndrome immunodéficitaire acquis sont également cités en exemple.
Harris-Kelson Tracy A.
Robert-Guroff Marjorie
Robey Frank A.
Fetherstonhaugh & Co.
The Government Of The United States Of America Represented By The Secre Tary Of The Department Of Health And Hu
LandOfFree
Peptomers with enhanced immunogenicity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptomers with enhanced immunogenicity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptomers with enhanced immunogenicity will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1842052